If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
278.00    -5.00 (-1.77%)
Bid:
276.00
Ask:
280.00
Spread: 4.00 (1.449%)
Market Cap: £248.96m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

AGM Statement and Q1 Trading Update

1 Nov 2018 07:00

RNS Number : 9329F
Wilmington PLC
01 November 2018
Β 

1 November 2018Β 

Β 

Wilmington plc

('Wilmington', 'the Group' or 'the Company')

AGM Statement and Q1 Trading Update

Β 

Wilmington plc, the provider of information, education and networking services in Risk & Compliance, Healthcare and Professional knowledge areas, today announces a trading update for the three month period to 30 September 2018. This statement is being made ahead of its Annual General Meeting that is taking place later today.

Β 

Trading Update

Β 

In what is traditionally the quietest trading period for the Group, revenue performance in the first quarter has been reasonable, with a mix of performances across the different divisions. Overall revenue reduced 1% on an organic basis (i.e. at constant currencies and after adjusting for acquisitions and disposals) compared to the same period last year. This compares to the 3% organic revenue decline experienced across the prior year.

Β 

On a divisional basis, revenue in the Risk & Compliance division was up 7% organically, with good momentum in the main Compliance business, partly as a result of favourable timing issues that accelerated revenue from Q2 into the first three months this year. In the Healthcare division revenue declined 7% on an organic basis reflecting the reduction in deferred revenue noted in September's full year results announcement, as well as the continued impact of the decision to reduce US networking events to focus on improving profitability. Importantly from the perspective of future revenue progression in Healthcare, new business sales in the first quarter in the UK Healthcare business were up over 2% year on year and early indications for Q2 are that sales are expected to be further up compared to weak comparatives in the prior year. Revenue in the Professional businesses was flat year on year, excluding the impact of Ark, the legal services business that was closed in the first half of last year.Β 

Β 

Profit in the period, as anticipated, was down year on year due to the previously disclosed cost increases and investments made last year. This position was exacerbated slightly by a weaker than expected product mix in Q1 although this is expected to be a timing issue that will reverse over the course of the full year.

Β 

Net debt at 30 September 2018 was Β£44.4m (30 June 2018: Β£39.6m; 30 September 2017: Β£42.4m). The outflow since the start of the year is a function of usual seasonal outflows, and the final earn-out payment for SWAT which was acquired in July 2016.

Β 

Outlook

Β 

There is no change in anticipated trading outlook since the full year 2018 results announcement on 12 September 2018. The overall outcome from the divisional revenue and sales performance in the first quarter gives some early encouragement that momentum across the Group is starting to shift as required to achieve full year revenue and profit expectations. Whilst uncertainties remain within the macro economic environment, the changes in regulations that will come into force in the UK as a result of Brexit are likely to lead to new business opportunities in the second half of the year which will help to underpin our growth plans.

Β 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Richard Amos, Chief Financial Officer

Β 

FTI Consulting

Charles PalmerΒ / Dwight Burden / Leah Dudley

020 7422 6800

Β 

Β 

Β 

020 3727 1000

Β 

Β 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed company on the main market of the London Stock Exchange.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCEAKEFDLLPFFF
Date   Source Headline
3rd Dec 20155:42 pmRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
26th Nov 20153:56 pmRNSDirector/PDMR Shareholding
10th Nov 20152:34 pmRNSHolding(s) in Company
6th Nov 201512:06 pmRNSHolding(s) in Company
5th Nov 20154:48 pmRNSResult of AGM
5th Nov 20157:00 amRNSAGM and Interim Management Statement
2nd Nov 201510:50 amRNSTotal Voting Rights
20th Oct 20156:16 pmRNSDirector/PDMR Shareholding
19th Oct 20154:03 pmRNSShare Awards
8th Oct 20154:47 pmRNSHolding(s) in Company
1st Oct 201510:24 amRNSTotal Voting Rights
25th Sep 20153:28 pmRNSHolding(s) in Company
17th Sep 20153:06 pmRNSShares Awards
15th Sep 20157:00 amRNSFinal Results
8th Sep 20157:00 amRNSBoard Changes
1st Sep 20152:19 pmRNSHolding(s) in Company
1st Sep 201512:20 pmRNSTotal Voting Rights
11th Aug 20152:00 pmRNSNotice of Results
6th Aug 20153:10 pmRNSHolding(s) in Company
3rd Aug 201511:33 amRNSTotal Voting Rights
31st Jul 20157:00 amRNSHolding(s) in Company
15th Jul 20154:42 pmRNSHolding(s) in Company
15th Jul 20157:00 amRNSHolding(s) in Company
8th Jul 201511:36 amRNSHolding(s) in Company
8th Jul 201511:30 amRNSHolding(s) in Company
7th Jul 20158:00 amRNSCapital Markets Day
7th Jul 20157:00 amRNSAcquisition of Financial Research Associates LLC
2nd Jul 201510:44 amRNSTotal Voting Rights
2nd Jul 20157:00 amRNSExtension of Debt Facility
2nd Jun 20159:19 amRNSPDMR Share Purchase
1st Jun 20153:08 pmRNSTotal Voting Rights
6th May 20157:01 amRNSInterim Management Statement
1st May 201510:14 amRNSTotal Voting Rights
1st Apr 201510:25 amRNSTotal Voting Rights
25th Mar 20154:44 pmRNSHolding(s) in Company
2nd Mar 201510:40 amRNSVoting Rights
27th Feb 20159:16 amRNSChange of Name
25th Feb 201511:58 amRNSShareholding Announcement
25th Feb 20157:01 amRNSHalf Year Results
19th Feb 20159:33 amRNSHolding(s) in Company
3rd Feb 20154:40 pmRNSTotal Voting Rights
26th Jan 201510:14 amRNSHolding(s) in Company
23rd Jan 20153:12 pmRNSHolding(s) in Company
23rd Jan 20151:59 pmRNSHolding(s) in Company
22nd Jan 201510:03 amRNSHolding(s) in Company
14th Jan 20153:54 pmRNSNotice of Results
5th Jan 20157:00 amRNSVoting Rights and Capital
10th Dec 20147:01 amRNSBoard Change
10th Dec 20147:00 amRNSInterim Update on Business Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.